ARCHIVES

Clearinghouse Completes Review of Backlog, Funds What Caused It, Reports On Program Value

This article is from The Cancer Letter archive.

Vol. 04 No. 20 | May 19, 1978

Download PDF Visit The Full Archive

Related Articles

FDA Advisory Committee To Consider NDAs On Novantrone, HD MTX

November 27, 1987

An Unlucky Streak? Doctors Analyze Errors As Another Cancer Center Offers Apology

June 30, 1995

CTI Files Appeal Over FDA’s Decision on Pixantrone

December 3, 2010

Battelle Wins Big Toxiology Contract

March 22, 1974

Proposed DRG Regulations Would Limit Exemptions To Fox Chase, M.D. Anderson; In Effect Oct. 1

September 9, 1983

NCI Cooperative Group Clinical Trials Approved

October 29, 2010